Research highlighting the regulation of interleukin-22 (IL-22) by AhR is of particular relevance to IBD as this cytokine impacts intestinal epithelial cell regeneration processes and is implicated in maintaining gut microbiome homeostasis (32, 35–39). Here, AHR is linked to inflammatory bowel disease.